Medical School Hannover
Hanover, Lower Saxony, 30449, Germany
Location status: Recruiting
Location contact
Hans Worthmann, PD Dr.
CONTACT
Johannes Teller, Dr.
CONTACT
NCT Number: NCT07568093
Postoperative agitation is a common and serious complication in visceral and transplant surgery, associated with prolonged hospital stays and an increased risk of self-harm. Therefore, it is important to find an approach to improve the management of postoperative agitation and to reduce its duration and severity. The medical device "PARO" is a robotic seal that enables patient-robot-interaction. Patients respond to the device through verbal communication and motor responses, as well as facial expressions and gestures. The seal detects human interaction through audiovisual recognition, tactile sensors, and the integration of artificial intelligence. The aim of the study is to observe the use of "PARO" in patients undergoing elective visceral surgery and to analyze the occurence of agitation.
A decrease in the incidence of postoperative agitation is to be expected in a cohort of patients undergoing visceral surgery who use PARO compared to a group of patients undergoing visceral surgery who do not use PARO.
To monitor the occurrence of postoperative agitation, a standardized screening will be conducted twice daily for three days using the Richmond Agitation-Sedation Scale (RASS). To assess postoperative pain, anxiety and delirium, the Numerical Pain Scale (NRS), the State-Trait-Anxiety-Inventory (STAI) and a delirium screening tool (3D-CAM/CAM-ICU) are used by a trained study team. The occurrence of other neuropsychiatric symptoms and postoperative surgical complications will also be assessed.
Additionally, the interaction between PARO and the patients is analyzed regarding movements, reactions to haptic and auditory stimuli, and the frequency of interaction. Our approach involves quantitatively monitoring these metrics to collect sensor data from the robot and video recordings of the patients to identify facial expression and posture patterns. The use and acceptance of the robot on clinical wards by various professional groups are evaluated. The focus is particularly on nursing staff, who have the most interactions with patients. The project is complemented by a hygiene study examining how successfully the hygiene protocol is integrated into clinical routines and what challenges the use of PARO poses in an intensive care unit. The aim is also to examine the workflow and time-related aspects of its usage. The study will be submitted as a clinical trial of the medical device within its intended use, without any additional invasive or burdensome procedures, in accordance with the provisions of Section 15 of the Medical Practitioners Act (MBO).
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Hanover, Lower Saxony, 30449, Germany
Location status: Recruiting
Hans Worthmann, PD Dr.
CONTACT
Johannes Teller, Dr.
CONTACT
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Patient inclusion criteria:
Patient exclusion criteria:
Robotic Seal "PARO"
Time frame: 1.-3.postoperative days
measured via Richmond-agitation-sedation-scale (RASS)
Time frame: Postoperative days 1-3
measured via State-Trait-Anxiety-Inventory (STAI)
Time frame: Postoperative days 1-3
measured via Numeric-Rating-scale (NRS)
Time frame: Postoperative days 1-3
measured via 3D-CAM/CAM-ICU
Contact information is provided by the study sponsor or research team.
Hans Worthmann, PD Dr.
CONTACT
Johannes Teller, Dr.
CONTACT
Hannover Medical School
Other
Postoperative Agitation, Anxiety and Pain With the Use of the Robotic Tool PARO - A Prospective Randomised Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07051096
Aberrant Motor Behavior in Dementia, Agitation
Vancouver, British Columbia, Canada
View Trial DetailsNCT02848963
Aberrant Motor Behavior in Dementia, Agitation
Adana, Sarıçam, Turkey (Türkiye)
View Trial DetailsNCT00857727
Aberrant Motor Behavior in Dementia, Agitation
New York, United States
View Trial DetailsNCT02194036
Aberrant Motor Behavior in Dementia, Agitation
Arendal, Aust-Agder, Norway
View Trial Details